Study Reveals Immune System's Role in Fatal Asthma Attacks
A fatal asthma attack is often perceived as a crisis occurring solely within the lungs, characterized by tightened airways, swelling, and mucus accumulation. However, a new study published in Nature Communications suggests that the origins of such attacks may involve immune responses occurring in other parts of the body, particularly in lymph nodes associated with the gut. This finding emerges from an investigation into why asthma can escalate to fatal levels in some individuals, despite being a common respiratory condition.
The research team, led by immunologists Yoonseung Lee and Donna Farber from Columbia University, analyzed tissue samples from 695 organ donors collected between 2012 and 2025. Among these donors, 41 had died during an asthma attack, 78 had asthma but succumbed to unrelated causes, and 576 had no documented asthma. The study revealed that every donor who died from a fatal asthma attack had elevated levels of immunoglobulin E (IgE), an antibody linked to allergic responses. This finding indicates a strong type 2 inflammatory response, which was also reflected in the lungs of these donors, where higher proportions of type 2 helper T cells, type 2 innate lymphoid cells, and mast cells were found. These cells, when overly active, can exacerbate swelling and mucus production, further narrowing the airways.
The researchers also examined lymph nodes, which serve as critical sites for immune cell communication and response preparation. Surprisingly, they found significant immune abnormalities not only in the lungs but also in lymph nodes associated with the gut. Lee noted that the most striking differences were observed in mucosal-associated lymph nodes, where memory T and B cells accumulated at younger ages in fatal asthma donors compared to those without asthma. This accumulation suggests that fatal asthma may involve earlier immune changes typically associated with aging.
While memory cells are essential for quick immune responses, their increased presence in asthma patients may lead to inappropriate inflammatory responses to harmless substances. Additionally, the study found a notable reduction in regulatory T cells, which help to modulate immune responses, in both asthma donors and those who died from an attack. This reduction suggests a fundamental association with asthma itself rather than being solely a consequence of the final exacerbation.
The connection to the gut became apparent when comparing immune activity across tissues. In fatal asthma cases, immune populations in the lungs showed more associations with responses in gut-associated lymph nodes than in individuals without asthma. This pattern raises the possibility that immune events contributing to an asthma attack may originate not just in the lungs but also in the gut or adjacent lymphoid tissues.
Importantly, Lee emphasized that the study demonstrates associations rather than causation. Each donor provided a single snapshot of immune activity, making it impossible to track the origins of the immune response or the movement of cells between tissues. Previous research has suggested links between certain gut bacteria and asthma risk, but this study did not investigate dietary factors or microbial influences. Instead, it focused on immune cells in lymph nodes near the intestines, without establishing that specific foods or microbes trigger fatal asthma attacks.
The study also faced limitations, including the relatively small number of fatal asthma cases and the lack of data on corticosteroid use, which can influence immune responses. Future research involving transcriptomic and spatial analyses may help clarify the molecular pathways and cellular interactions at play. For now, these findings underscore the complexity of fatal asthma, suggesting that the immune system's preparation for an attack may extend beyond the lungs, potentially involving the gut. The study was published in Nature Communications, and while it offers new insights, it does not provide a new diagnostic test or treatment for asthma.




